Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PL 3994

Drug Profile

PL 3994

Alternative Names: PL-3994

Latest Information Update: 29 Nov 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Palatin Technologies
  • Class Antiasthmatics; Heart failure therapies; Natriuretic peptides
  • Mechanism of Action Atrial natriuretic factor receptor A agonists; Diuretics; Natriuretic peptide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Asthma

Highest Development Phases

  • Phase II Heart failure
  • No development reported Acute asthma

Most Recent Events

  • 29 Nov 2022 PL 3994 is still in phase II trials for Heart failure in USA (IV, Infusion)
  • 04 May 2020 Phase-II clinical trials in Heart failure in USA (IV) (NCT04318145)
  • 30 Apr 2020 Palatin Technologies plans a phase IIa trial for Heart failure (IV) in fourth quarter of 2020(NCT04318145)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top